Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Medicare Incentives For Quality Drugs Should Not Wait For US FDA Ratings, Experts Tell Congress

Dec 09 2023

• By Bowman Cox

Thumbs up for drug quality — why pay for quality • Source: Shutterstock

Related Content

US FDA And OMB Should ‘Pause’ Billion-Dollar Quality Metrics Program, Industry Groups Say

Mar 30 2017

What Carrots Will US FDA Offer For Quality Management Maturity Participation?

Apr 19 2023

Rx Rebating Bills In House, Senate Come Into Alignment As Passage Likely Punted to 2024

Nov 29 2023

Brookings’ Drug Shortages Remedies Target Both Hospitals And Manufacturers

Jun 26 2023

US FDA's Cavazzoni Criticizes Plant Shutdown That Triggered Serious Cisplatin Shortage

Sep 21 2023

It’s Time For The Feds To Get Into Drug Manufacturing, Senator Warren Says

Dec 19 2018

Additional Topics

United States Supply Chain Quality Legislation Pricing Debate Manufacturing Generic Drugs BioPharmaceutical

More from Distribution/Supply Chain

More from Compliance

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window